Physician profile
Benjamin Heaton
NPI 1245468586
$638.45
in general payments reported to CMS, 2019-2025
16 companies · $64.40 in 2025
The $64.40 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $574 · 2025: $64.40.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $638.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $638.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $85.95 | 2024-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Lilly USA, LLC | $83.98 | 2024 | Zepbound, Jardiance, Mounjaro |
| Astrazeneca Pharmaceuticals LP | $66.84 | 2024 | Farxiga, Airsupra |
| Novo Nordisk INC | $58.07 | 2024 | Wegovy |
| Amgen INC. | $46.14 | 2024 | Prolia, Evenity, Tavneos |
| Idorsia Pharmaceuticals US INC | $39.56 | 2024 | Quviviq |
| Exact Sciences Corporation | $35.81 | 2024-2025 | Cologuard Collection Kit |
| Inspire Medical Systems, INC. | $34.50 | 2025 | Inspire |
| Novartis Pharmaceuticals Corporation | $27.86 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $26.20 | 2024 | |
| Phathom Pharmaceuticals, INC. | $25.16 | 2024 | Voquezna |
| Abbott Laboratories | $24.59 | 2024 | Freestyle Libre 3 |
| Amneal Pharmaceuticals LLC | $24.57 | 2024 | Rytary |
| Itf Therapeutics LLC | $21.37 | 2024 | |
| Astellas Pharma US INC | $19.16 | 2024 | Veozah |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $18.69 | 2024 | Dexcom G6 Transmitter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Heaton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.